![]() |
市场调查报告书
商品编码
1833674
眼底照相机市场机会、成长动力、产业趋势分析及 2025 - 2034 年预测Fundus Cameras Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025 - 2034 |
2024 年全球眼底相机市场价值为 5.152 亿美元,预计将以 5.2% 的复合年增长率成长,到 2034 年达到 8.548 亿美元。
由于眼部疾病的增加、老年人口的扩大、成像技术的快速进步以及政府和医疗机构为加强视力保健而采取的倡议不断增多,市场正在持续增长。对慢性眼疾早期诊断和管理的需求日益增长,促使医疗机构越来越多地采用先进的视网膜影像工具。向远距医疗服务的转变也在扩大眼科护理的可近性方面发挥了至关重要的作用,尤其是在医疗服务不足的地区。整合数位技术的眼底照相机使医疗保健提供者能够更轻鬆地进行远端筛检,从而能够及早发现病情并减少亲自就诊的需求。产品设计的持续创新,包括紧凑且用户友好的介面,改善了临床工作流程并提高了效率。将光学相干断层扫描与眼底成像技术结合在一台设备中也正在改变眼科医生诊断和治疗患者的方式,提供高解析度、全面的视网膜评估,从而节省时间和资源。
市场范围 | |
---|---|
起始年份 | 2024 |
预测年份 | 2025-2034 |
起始值 | 5.152亿美元 |
预测值 | 8.548亿美元 |
复合年增长率 | 5.2% |
免散瞳眼底照相机市场在2024年占据了52.8%的市场份额,这得益于其无需散瞳即可快速高效成像的优势。这类相机在基层医疗机构和远距眼科计画中广受欢迎,成为高通量眼疾筛检的理想选择。其易用性和患者舒适度有助于提高临床和远端环境下的依从性和可近性。这些系统消除了传统散瞳过程带来的不适和延迟,使其成为第一线筛检和定期眼科检查的首选。
眼科诊所市场在2024年占据59.6%的份额,到2034年将达到5.129亿美元。诊所是诊断和持续治疗黄斑部病变、糖尿病视网膜病变和青光眼等眼部疾病的主要中心。随着这些慢性疾病在全球范围内的发病率持续增长,诊所越来越多地采用先进的诊断解决方案,以支持更快、更准确的治疗。许多诊所正在转向将眼底照相与OCT技术相结合的混合成像系统,以便在一次诊疗中完成全面的评估。
2024年,北美眼底照相机市场占41.6%的市占率。该地区受益于强大的医疗基础设施、完善的眼科诊断检查报销体係以及政府在预防保健方面的积极参与。保险覆盖范围极大地支持了医院、诊所和专科中心对眼底照相机的采用。北美在采用先进的眼科技术方面也处于领先地位,尤其是支援人工智慧和混合技术的系统,这些技术可以简化成像流程并提高诊断准确性。
全球眼底照相机市场的主要製造商和供应商包括蔡司、Nikon(Optos)、尼德克、拓普康、Canon、三星、维信诺、epipole、Forus Health、Huvitz、Kowa、OPTOMED、Remidio、REVENIO 和 Volk Optical。为了获得竞争优势,眼底照相机市场的领先公司专注于持续的产品开发、与数位平台的智慧整合以及全球业务的拓展。许多公司正在透过人工智慧、云端储存和远距医疗相容性来增强其设备,以满足不断变化的临床需求。与医疗保健提供者、非政府组织和政府计画的合作有助于公司打入新兴市场并改善偏远地区的筛检服务。
The Global Fundus Cameras Market was valued at USD 515.2 million in 2024 and is estimated to grow at a CAGR of 5.2% to reach USD 854.8 million by 2034.
The market is seeing consistent growth due to an increase in eye-related disorders, expanding geriatric populations, rapid improvements in imaging technology, and growing initiatives by governments and healthcare organizations to enhance vision care. Rising demand for early diagnosis and management of chronic eye diseases is increasing the adoption of advanced retinal imaging tools across medical settings. The transition to telehealth services has also played a vital role in broadening access to eye care, especially in underserved areas. Fundus cameras integrated with digital technologies are making it easier for healthcare providers to conduct remote screenings, enabling early detection of conditions and reducing the need for in-person visits. Continued innovation in product design, including compact and user-friendly interfaces, has enhanced clinical workflows and boosted efficiency. The combination of optical coherence tomography with fundus imaging in a single device is also transforming how ophthalmologists diagnose and treat patients, providing high-resolution, comprehensive retinal evaluations that save both time and resources.
Market Scope | |
---|---|
Start Year | 2024 |
Forecast Year | 2025-2034 |
Start Value | $515.2 million |
Forecast Value | $854.8 million |
CAGR | 5.2% |
The non-mydriatic fundus cameras segment accounted for a 52.8% share in 2024, fueled by their ability to perform quick and efficient imaging without the need for pupil dilation. These cameras have gained widespread popularity across primary care settings and teleophthalmology programs, making them ideal for high-throughput eye disease screening. Their ease of use and patient comfort have helped improve compliance and accessibility in both clinical and remote settings. These systems eliminate the discomfort and delay of traditional dilation processes, making them the preferred choice for first-line screening and regular eye checkups.
The ophthalmology clinics segment held a 59.6% share in 2024 and will reach USD 512.9 million by 2034. Clinics serve as the main centers for diagnosis and ongoing treatment of eye conditions such as macular degeneration, diabetic retinopathy, and glaucoma. As the incidence of these chronic diseases continues to grow globally, clinics are increasingly adopting advanced diagnostic solutions to support faster and more accurate care. Many are turning to hybrid imaging systems that combine fundus photography with OCT technology for comprehensive assessments in a single session.
North America Fundus Cameras Market held a 41.6% share in 2024. The region benefits from strong healthcare infrastructure, well-defined reimbursement systems for diagnostic eye exams, and proactive government involvement in preventive care. Insurance coverage significantly supports the uptake of fundus cameras in hospitals, clinics, and specialty centers. North America also leads in embracing advanced ophthalmic technologies, particularly AI-enabled and hybrid systems that streamline imaging and enhance diagnostic accuracy.
Major manufacturers and suppliers in the Global Fundus Cameras Market include ZEISS, Nikon (Optos), NIDEK, TOPCON, Canon, Samsung, Visionix, epipole, Forus Health, Huvitz, Kowa, OPTOMED, Remidio, REVENIO, and Volk Optical. To gain a competitive edge, leading companies in the fundus cameras market are focusing on continuous product development, smart integration with digital platforms, and expanding global reach. Many are enhancing their devices with artificial intelligence, cloud-based storage, and telehealth compatibility to meet evolving clinical demands. Partnerships with healthcare providers, NGOs, and government programs help companies penetrate emerging markets and improve screening access in remote areas.